Pfizer Must Face Claims It Didn't Monitor Chantix Risks
Pfizer Inc. must face claims that it failed to properly monitor smoking-cessation drug Chantix for potential side effects like severe muscle disorders, spasms and even death, the New York Supreme Court...To view the full article, register now.
Already a subscriber? Click here to view full article